G. Simonneau, D. Montani, D. S. Celermajer, C. P. Denton, M. A. Gatzoulis et al., Haemodynamic definitions and updated clinical classification of pulmonary hypertension, Eur Respir J, vol.53, issue.1, 2019.

S. Rich, L. J. Rubin, and L. Abenhail, Executive Summary From the World Symposium on Primary Pulmonary Hypertension, World Health Organization, vol.1998, pp.1-27, 1998.

M. Madani, T. Ogo, and G. Simonneau, The changing landscape of chronic thromboembolic pulmonary hypertension management, Eur Respir Rev Off J Eur Respir Soc, vol.26, issue.146, 2017.

E. Mahmud, M. M. Madani, N. H. Kim, D. Poch, L. Ang et al., Chronic Thromboembolic Pulmonary Hypertension: Evolving Therapeutic Approaches for Operable and Inoperable Disease, J Am Coll Cardiol, vol.71, issue.21, pp.2468-86, 201829.

N. Galiè and N. Kim, Pulmonary microvascular disease in chronic thromboembolic pulmonary hypertension, Proc Am Thorac Soc, vol.3, issue.7, pp.571-577, 2006.

P. Dartevelle, E. Fadel, S. Mussot, A. Chapelier, P. Hervé et al., Chronic thromboembolic pulmonary hypertension, Eur Respir J, vol.23, issue.4, pp.637-685, 2004.
URL : https://hal.archives-ouvertes.fr/hal-01764863

G. Simonneau, A. Torbicki, P. Dorfmüller, and N. Kim, The pathophysiology of chronic thromboembolic pulmonary hypertension, Eur Respir Rev Off J Eur Respir Soc, vol.26, issue.143, 2017.

R. Azarian, M. Wartski, M. A. Collignon, F. Parent, P. Hervé et al., Lung perfusion scans and hemodynamics in acute and chronic pulmonary embolism, J Nucl Med Off Publ Soc Nucl Med, vol.38, issue.6, pp.980-983, 1997.

K. M. Moser and C. M. Bloor, Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension, Chest, vol.103, issue.3, pp.685-92, 1993.

P. Dorfmüller, S. Günther, M. Ghigna, T. De-montpréville, V. Boulate et al., Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature, Eur Respir J, vol.44, issue.5, pp.1275-88, 2014.

I. M. Lang, Chronic thromboembolic pulmonary hypertension--not so rare after all, N Engl J Med, vol.350, issue.22, pp.2236-2244, 2004.

A. Ribeiro, P. Lindmarker, H. Johnsson, A. Juhlin-dannfelt, and L. Jorfeldt, Pulmonary embolism: one-year follow-up with echocardiography doppler and five-year survival analysis. Circulation, vol.99, pp.1325-1355, 1999.

T. A. Morris, J. J. Marsh, P. G. Chiles, M. M. Magaña, N. Liang et al., High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension, Blood, vol.114, issue.9, pp.1929-1965, 2009.

M. Rabinovitch, Pulmonary hypertension: pathophysiology as a basis for clinical decision making, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, vol.18, issue.11, pp.1041-53, 1999.

M. Southwood, M. Ross, R. V. Kuc, R. E. Hagan, G. Sheares et al., Endothelin ETA receptors predominate in chronic thromboembolic pulmonary hypertension, Life Sci, vol.159, pp.104-114, 2016.

O. Mercier and E. Fadel, Chronic thromboembolic pulmonary hypertension: animal models, Eur Respir J, vol.41, issue.5, pp.1200-1206, 2013.

S. W. Jamieson and D. P. Kapelanski, Pulmonary endarterectomy, Curr Probl Surg, vol.37, issue.3, pp.165-252, 2000.

P. A. Thistlethwaite, M. Mo, M. M. Madani, R. Deutsch, D. Blanchard et al., Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy, J Thorac Cardiovasc Surg, vol.124, issue.6, pp.1203-1214, 2002.

S. W. Jamieson, D. P. Kapelanski, N. Sakakibara, G. R. Manecke, P. A. Thistlethwaite et al., Pulmonary endarterectomy: experience and lessons learned in 1,500 cases, Ann Thorac Surg, vol.76, issue.5, pp.1462-1464, 2003.

K. M. Mcintyre and A. A. Sasahara, The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease, Am J Cardiol, vol.28, issue.3, pp.288-94, 1971.

M. Delcroix, I. Lang, J. Pepke-zaba, P. Jansa, D. 'armini et al., Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry, Circulation, vol.133, issue.9, pp.859-71, 2016.

R. H. White, The epidemiology of venous thromboembolism. Circulation, vol.107, pp.4-8, 2003.

C. Becattini, G. Agnelli, R. Pesavento, M. Silingardi, R. Poggio et al., Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism, Chest, vol.130, issue.1, pp.172-177, 2006.

M. M. Hoeper, E. Mayer, G. Simonneau, and L. J. Rubin, Chronic thromboembolic pulmonary hypertension, Circulation, vol.113, issue.16, pp.2011-2031, 2006.

V. Pengo, A. Lensing, M. H. Prins, A. Marchiori, B. L. Davidson et al., Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism, N Engl J Med, vol.350, issue.22, pp.2257-64, 2004.

L. Guérin, F. Couturaud, F. Parent, M. Revel, F. Gillaizeau et al., Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism, Thromb Haemost, vol.112, issue.3, pp.598-605, 2014.

X. Jaïs, V. Ioos, C. Jardim, O. Sitbon, F. Parent et al., Splenectomy and chronic thromboembolic pulmonary hypertension, Thorax, vol.60, issue.12, pp.1031-1035, 2005.

D. Bonderman, H. Wilkens, S. Wakounig, H. Schäfers, P. Jansa et al., Risk factors for chronic thromboembolic pulmonary hypertension, Eur Respir J, vol.33, issue.2, pp.325-356, 2009.

D. Bonderman, J. Jakowitsch, C. Adlbrecht, M. Schemper, P. A. Kyrle et al., Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension, Thromb Haemost, vol.93, issue.3, pp.512-518, 2005.

M. Wolf, C. Boyer-neumann, F. Parent, V. Eschwege, H. Jaillet et al., Thrombotic risk factors in pulmonary hypertension, Eur Respir J, vol.15, issue.2, pp.395-404, 2000.

M. Riedel, V. Stanek, J. Widimsky, and I. Prerovsky, Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data, Chest, vol.81, issue.2, pp.151-159, 1982.

N. Tunariu, S. Gibbs, Z. Win, W. Gin-sing, A. Graham et al., Ventilationperfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension, J Nucl Med Off Publ Soc Nucl Med, vol.48, issue.5, pp.680-684, 2007.

W. R. Auger, P. F. Fedullo, K. M. Moser, M. Buchbinder, and K. L. Peterson, Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography, Radiology, vol.182, issue.2, pp.393-401, 1992.

E. Mayer, D. Jenkins, J. Lindner, D. 'armini, A. Kloek et al., Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry, J Thorac Cardiovasc Surg, vol.141, issue.3, pp.702-712, 2011.

R. Azarian, M. Wartski, M. A. Collignon, F. Parent, P. Hervé et al., Lung perfusion scans and hemodynamics in acute and chronic pulmonary embolism, J Nucl Med Off Publ Soc Nucl Med, vol.38, issue.6, pp.980-983, 1997.

R. Azarian, F. Brenot, O. Sitbon, D. Musset, G. Grimon et al.,

, Presse Medicale Paris Fr, vol.23, issue.22, pp.1017-1039, 1983.

K. M. Moser and N. S. Braunwald, Successful surgical intervention in severe chronic thromboembolic pulmonary hypertension, Chest, vol.64, issue.1, pp.29-35, 1973.

P. Dartevelle, E. Fadel, A. Chapelier, P. Macchiarini, J. Cerrina et al., Pulmonary thromboendarterectomy with video-angioscopy and circulatory arrest: an alternative to cardiopulmonary transplantation and post-embolism pulmonary artery hypertension

, Chir Memoires Acad Chir, vol.123, pp.32-40, 1998.

S. Guth, C. B. Wiedenroth, T. Kramm, and E. Mayer, Pulmonary endarterectomy for the treatment of chronic thromboembolic pulmonary hypertension, Expert Rev Respir Med, vol.10, issue.6, pp.673-84, 2016.

M. Madani, E. Mayer, E. Fadel, and D. P. Jenkins, Pulmonary Endarterectomy. Patient Selection, Technical Challenges, and Outcomes, vol.13, pp.240-247, 2016.

D. Jenkins, Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension, Eur Respir Rev Off J Eur Respir Soc, vol.24, issue.136, pp.263-71, 2015.

K. C. Lee, Y. L. Cho, and S. Y. Lee, Reperfusion pulmonary edema after pulmonary endarterectomy, Acta Anaesthesiol Sin, vol.39, issue.2, pp.97-101, 2001.

R. M. Levinson, D. Shure, and K. M. Moser, Reperfusion pulmonary edema after pulmonary artery thromboendarterectomy, Am Rev Respir Dis, vol.134, issue.6, pp.1241-1246, 1986.

D. H. Freed, B. M. Thomson, S. Tsui, J. J. Dunning, K. K. Sheares et al., Functional and haemodynamic outcome 1 year after pulmonary thromboendarterectomy

J. Eur and . Surg, , vol.34, pp.529-530, 2008.

M. M. Madani, W. R. Auger, V. Pretorius, N. Sakakibara, K. M. Kerr et al., Pulmonary Endarterectomy: Recent Changes in a Single Institution's Experience of More Than 2,700 Patients, Ann Thorac Surg, vol.94, issue.1, pp.97-103, 2012.

N. Galiè, M. Humbert, J. Vachiery, S. Gibbs, I. Lang et al., ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT), Eur Heart J, vol.37, issue.1, pp.67-119, 2015.

M. Kataoka, T. Inami, K. Hayashida, N. Shimura, H. Ishiguro et al., Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension, Circ Cardiovasc Interv, vol.5, issue.6, pp.756-62, 2012.

Y. Taniguchi, K. Miyagawa, K. Nakayama, H. Kinutani, T. Shinke et al., Balloon pulmonary angioplasty: an additional treatment option to improve the prognosis of patients with chronic thromboembolic pulmonary hypertension, EuroIntervention J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol, vol.10, issue.4, pp.518-543, 2014.

H. Mizoguchi, A. Ogawa, M. Munemasa, H. Mikouchi, H. Ito et al., Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension, Circ Cardiovasc Interv, vol.5, issue.6, pp.748-55, 2012.

P. Brenot, X. Jaïs, Y. Taniguchi, G. Alonso, C. Gerardin et al., French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension, Eur Respir J, vol.53, issue.5, 2019.

T. Inami, M. Kataoka, N. Shimura, H. Ishiguro, R. Yanagisawa et al., Pulmonary edema predictive scoring index (PEPSI), a new index to predict risk of reperfusion pulmonary edema and improvement of hemodynamics in percutaneous transluminal pulmonary angioplasty, JACC Cardiovasc Interv, vol.6, issue.7, pp.725-761, 2013.

S. Fukui, T. Ogo, Y. Morita, A. Tsuji, E. Tateishi et al., Right ventricular reverse remodelling after balloon pulmonary angioplasty, Eur Respir J, vol.43, issue.5, pp.1394-402, 2014.

T. Inami, M. Kataoka, M. Ando, K. Fukuda, H. Yoshino et al., A new era of therapeutic strategies for chronic thromboembolic pulmonary hypertension by two different interventional therapies; pulmonary endarterectomy and percutaneous transluminal pulmonary angioplasty, PloS One, vol.9, issue.4, p.94587, 2014.

Y. Taniguchi, K. Miyagawa, K. Nakayama, H. Kinutani, T. Shinke et al., Balloon pulmonary angioplasty: an additional treatment option to improve the prognosis of patients with chronic thromboembolic pulmonary hypertension, EuroIntervention J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol, vol.10, issue.4, pp.518-543, 2014.

T. Aoki, K. Sugimura, S. Tatebe, M. Miura, S. Yamamoto et al., Comprehensive evaluation of the effectiveness and safety of balloon pulmonary angioplasty for inoperable chronic thrombo-embolic pulmonary hypertension: long-term effects and procedure-related complications, Eur Heart J, vol.38, issue.42, pp.3152-3161, 2017.

N. Galiè, J. A. Barberà, A. E. Frost, H. Ghofrani, M. M. Hoeper et al., Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension, N Engl J Med, vol.373, issue.9, pp.834-878, 2015.

J. Pepke-zaba, H. Ghofrani, and M. M. Hoeper, Medical management of chronic thromboembolic pulmonary hypertension, Eur Respir Rev Off J Eur Respir Soc, vol.26, issue.143, 2017.

H. Ghofrani, D. 'armini, A. M. Grimminger, F. Hoeper, M. M. Jansa et al., Riociguat for the treatment of chronic thromboembolic pulmonary hypertension, N Engl J Med, vol.369, issue.4, pp.319-348, 2013.

R. Sadushi-kolici, P. Jansa, G. Kopec, A. Torbicki, N. Skoro-sajer et al., Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial, Lancet Respir Med, vol.7, issue.3, pp.239-287, 2019.

H. Ghofrani, G. Simonneau, D. 'armini, A. M. Fedullo, P. Howard et al., Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, doubleblind, placebo-controlled study, Lancet Respir Med, vol.5, issue.10, pp.785-94, 2017.

G. Simonneau, D. 'armini, A. M. Ghofrani, H. Grimminger, F. Hoeper et al., Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a longterm extension study (CHEST-2), Eur Respir J, vol.45, issue.5, pp.1293-302, 2015.

X. Jaïs, D. 'armini, A. M. Jansa, P. Torbicki, A. Delcroix et al., Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial, J Am Coll Cardiol, vol.52, issue.25, pp.2127-2161, 2008.

J. Suntharalingam, C. M. Treacy, N. J. Doughty, K. Goldsmith, E. Soon et al., Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension, Chest, vol.134, issue.2, pp.229-265, 2008.

H. J. Reesink, S. Surie, J. J. Kloek, H. L. Tan, R. Tepaske et al., Bosentan as a bridge to pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension, J Thorac Cardiovasc Surg, vol.139, issue.1, pp.85-91, 2010.

P. Bresser, P. F. Fedullo, W. R. Auger, R. N. Channick, I. M. Robbins et al., Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension, Eur Respir J, vol.23, issue.4, pp.595-600, 2004.

N. Nagaya, N. Sasaki, M. Ando, H. Ogino, F. Sakamaki et al., Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension, Chest, vol.123, issue.2, pp.338-381, 2003.

C. B. Wiedenroth, H. A. Ghofrani, M. Adameit, A. Breithecker, M. Haas et al., Sequential treatment with riociguat and balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension, Pulm Circ, vol.8, issue.3, p.2045894018783996, 2018.

M. Gabrielly, Initial dual oral combination therapy in inoperable chronic thromboembolic pulmonary hypertension (CTEPH). The European Respiratory Journal, 2018.

J. E. Cannon, L. Su, D. G. Kiely, K. Page, M. Toshner et al., Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort, Circulation, vol.133, issue.18, pp.1761-71, 2016.

K. W. Jensen, K. M. Kerr, P. F. Fedullo, N. H. Kim, V. J. Test et al., Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy, Circulation, vol.120, issue.13, pp.1248-54, 2009.

J. Pepke-zaba, A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Multicentre, Prospective Study to Assess Efficacy of Riociguat in Patients With Operable CTEPH Prior to Pulmonary Endarterectomy With High Preoperative Pulmonary Vascular Resistance

G. G. Pietra, F. Capron, S. Stewart, O. Leone, M. Humbert et al., Pathologic assessment of vasculopathies in pulmonary hypertension, J Am Coll Cardiol, vol.43, issue.12, pp.25-32, 2004.